Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
نویسندگان
چکیده
منابع مشابه
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Botulinum toxin A is increasingly used in the treatment of idiopathic and symptomatic headache disorders. However, only few controlled trials are available and many trials can hardly be compared to each other because of different endpoints and different trial designs. In particular chronic daily headache, which is defined as an idiopathic headache occurring on more than 15 days per month for at...
متن کاملBotulinum toxin for treatment of primary chronic headache disorders.
Migraine. Since the 2002 TEC Assessment, 1 new study meeting selection criteria has appeared. Published in 2004 (n=60), this trial randomized patients to saline placebo, low-dose BTX-A, or high-dose BTX-A. No significant differences were reported at 3 months for any of 7 pain-related outcomes. The low dose of BTX-A had a lower rate of accompanying symptoms (photophobia, phonophobia, nausea and ...
متن کاملAcupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
Background: Migraine is a common type of headache. Sometimes adequate pain relief is not achieved by conventional treatments. Acupuncture and botulinum toxin-A injection are known as non-pharmacological interventions for this purpose. The aim of this research was to compare the effect of acupuncture with botulinum toxin-A injection and pharmacological treatment in controlling chronic migraine. ...
متن کاملBotulinum toxin type a as a prophylactic treatment for chronic daily headache: time to conduct a large clinical trial in Taiwan?
متن کامل
Common Prophylactic Practices for Chronic Daily Headache*
A variety of medications and treatment interventions, including antiepileptic drugs, tricyclic antidepressants, selective serotonin reuptake inhibitors, combined serotonin and norepinephrine reuptake inhibitors, β blockers, calcium channel antagonists, α2-adrenergic agonists, nonsteroidal anti-inflammatory drugs, muscle relaxants, occipital nerve blocks, and botulinum toxin type A injections, h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuropsychiatric Disease and Treatment
سال: 2008
ISSN: 1178-2021
DOI: 10.2147/ndt.s1665